EcoDrugPlus

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSOTSG00005046837
Gene Symbol: PSMA8
3 Cross references
167 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSOTSG00005024859
Gene Symbol: PSMB1
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSOTSG00005025990
Gene Symbol: PSMB1
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSOTSG00005004203
Gene Symbol: PSMB1
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSOTSG00005021055
Gene Symbol: PSMB10
1 Cross references
164 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSOTSG00005036432
Gene Symbol: PSMB10
1 Cross references
164 Possible Orthologues:

Proteasome 20s Subunit Beta 11b

Ensembl ID : ENSOTSG00005039307
Gene Symbol: PSMB11B
1 Cross references
159 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSOTSG00005010117
Gene Symbol: PSMB2
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSOTSG00005030335
Gene Symbol: PSMB2
1 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSOTSG00005027150
Gene Symbol: PSMB4
1 Cross references
207 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSOTSG00005045867
Gene Symbol: PSMB4
1 Cross references
207 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSOTSG00005006266
Gene Symbol: PSMB4
1 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).